Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5220)
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
8,149
Price
$70.50
Total Value
$574.50K
Shares Held After
600,834
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,557
Price
$69.40
Total Value
$246.86K
Shares Held After
608,983
% of Holdings
0.6%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
572
Price
$220.67
Total Value
$126.22K
Shares Held After
137,643
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
213
Price
$219.34
Total Value
$46.72K
Shares Held After
138,215
% of Holdings
0.2%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
413
Price
$218.84
Total Value
$90.38K
Shares Held After
138,428
% of Holdings
0.3%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,802
Price
$217.52
Total Value
$391.97K
Shares Held After
138,841
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
3,100
Price
$72.06
Total Value
$223.39K
Shares Held After
97,994
% of Holdings
3.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,599
Price
$70.77
Total Value
$183.93K
Shares Held After
101,094
% of Holdings
2.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,801
Price
$69.75
Total Value
$125.62K
Shares Held After
103,693
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,401
Price
$68.35
Total Value
$369.14K
Shares Held After
767,780
% of Holdings
0.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
12,989
Price
$67.41
Total Value
$875.59K
Shares Held After
773,181
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,610
Price
$66.39
Total Value
$106.88K
Shares Held After
786,170
% of Holdings
0.2%
Replimune Group, Inc. (REPL)
Sarchi Christopher — Chief Commercial Officer
Shares
12,000
Price
$9.24
Total Value
$110.88K
Shares Held After
180,962
% of Holdings
6.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
828
Price
$439.91
Total Value
$364.25K
Shares Held After
19,959
% of Holdings
4.0%
BeOne Medicines Ltd. (ONC)
Yi Qingqing — Director
Shares
235
Price
$279.13
Total Value
$65.60K
Shares Held After
0
% of Holdings
100.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
3,931
Price
$70.75
Total Value
$278.10K
Shares Held After
8,977
% of Holdings
30.5%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
21,069
Price
$70.11
Total Value
$1.48M
Shares Held After
12,908
% of Holdings
62.0%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
40,000
Price
$70.00
Total Value
$2.80M
Shares Held After
15,257
% of Holdings
72.4%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
2,889
Price
$29.66
Total Value
$85.70K
Shares Held After
793
% of Holdings
78.5%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
1,346
Price
$28.79
Total Value
$38.76K
Shares Held After
3,682
% of Holdings
26.8%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
1,700
Price
$27.78
Total Value
$47.23K
Shares Held After
5,028
% of Holdings
25.3%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Shares
2,254
Price
$1.54
Total Value
$3.47K
Shares Held After
457,711
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Shares
2,434
Price
$1.54
Total Value
$3.75K
Shares Held After
459,965
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Shares
1,557
Price
$1.54
Total Value
$2.40K
Shares Held After
462,399
% of Holdings
0.3%
Pulmonx Corp (LUNG)
Rose Geoffrey Beran — CHIEF COMMERCIAL OFFICER
Shares
1,778
Price
$1.54
Total Value
$2.74K
Shares Held After
463,956
% of Holdings
0.4%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
38,467
Price
$1.54
Total Value
$59.24K
Shares Held After
1,191,673
% of Holdings
3.1%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
4,171
Price
$1.54
Total Value
$6.42K
Shares Held After
1,230,140
% of Holdings
0.3%
NEXGEL, INC. (NXGL)
Levy Adam R. — Director
Shares
2,000
Price
$0.59
Total Value
$1.17K
Shares Held After
342,692
% of Holdings
0.6%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
5,969
Price
$1.54
Total Value
$9.19K
Shares Held After
331,239
% of Holdings
1.8%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
3,684
Price
$1.54
Total Value
$5.67K
Shares Held After
337,208
% of Holdings
1.1%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
2,153
Price
$1.54
Total Value
$3.32K
Shares Held After
340,892
% of Holdings
0.6%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
2,691
Price
$1.54
Total Value
$4.14K
Shares Held After
343,045
% of Holdings
0.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$20.86
Total Value
$5.80K
Shares Held After
1,668
% of Holdings
14.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$20.86
Total Value
$5.80K
Shares Held After
1,668
% of Holdings
14.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$20.86
Total Value
$5.80K
Shares Held After
1,668
% of Holdings
14.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$20.86
Total Value
$5.80K
Shares Held After
1,668
% of Holdings
14.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,153
Price
$20.86
Total Value
$24.05K
Shares Held After
36,908
% of Holdings
3.0%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,357
Price
$20.86
Total Value
$28.30K
Shares Held After
43,424
% of Holdings
3.0%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
6,214
Price
$20.86
Total Value
$129.61K
Shares Held After
21,479
% of Holdings
22.4%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
4,915
Price
$1.54
Total Value
$7.57K
Shares Held After
376,161
% of Holdings
1.3%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
3,539
Price
$1.54
Total Value
$5.45K
Shares Held After
381,076
% of Holdings
0.9%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
2,264
Price
$1.54
Total Value
$3.49K
Shares Held After
384,615
% of Holdings
0.6%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
3,876
Price
$1.54
Total Value
$5.97K
Shares Held After
386,879
% of Holdings
1.0%
EXELIXIS, INC. (EXEL)
WYSZOMIERSKI JACK L — Director
Shares
3,925
Price
$50.55
Total Value
$198.41K
Shares Held After
284,384
% of Holdings
1.4%
EXELIXIS, INC. (EXEL)
Eckhardt Sue Gail — Director
Shares
9,812
Price
$50.14
Total Value
$491.97K
Shares Held After
16,079
% of Holdings
37.9%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
80,459
Price
$0.47
Total Value
$37.82K
Shares Held After
542,120
% of Holdings
12.9%
AdaptHealth Corp. (AHCO)
Schuster III Russell E. — Chief Commercial Officer
Shares
11,275
Price
$10.06
Total Value
$113.43K
Shares Held After
136,538
% of Holdings
7.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
17
Price
$302.65
Total Value
$5.15K
Shares Held After
1,582
% of Holdings
1.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
495
Price
$300.72
Total Value
$148.86K
Shares Held After
1,599
% of Holdings
23.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
1,222
Price
$299.87
Total Value
$366.44K
Shares Held After
2,094
% of Holdings
36.9%
Showing 1051–1100 of 5220 transactions (page 22 of 105)